ecessity and effectiveness of empirical antibiotic use in mild to moderate acute inflammatory gallbladder disease;

Not Applicable

• Conditions: Diseases of the digestive system

• Registration Number: KCT0008240
• Lead Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 370

Inclusion Criteria

? Patients who are scheduled to undergo laparoscopic surgery among patients with acute cholecystitis who have no evidence of systemic infection between the ages of 19 and 70
? Patients with acute cholecystitis with preserved gallbladder walls in the group of patients with acute cholecystitis (grade I by Tokyo guidelines) and moderate (grade II)
? Cholecystitis with gallbladder wall thickness of more than 4mm or adhesion to surrounding organs due to gallbladder inflammation
? A person who voluntarily signs a written consent form after hearing and understanding the description of this clinical trial

Exclusion Criteria

? Those who are scheduled to undergo elective gallbladder surgery (chronic cholecystitis, etc.)
? gallbladder disease, not inflammatory disease (GB Cancer, GB polyp)
? Among the patients with acute cholecystitis, patients with grade II or III by Tokyo guidelines with unpreserved gallbladder walls
? Pregnant or lactating women
? A person who performs surgery simultaneously due to other organ diseases.
? Those with immunosuppressive and hemorrhagic tendencies
? A person who performed percutaneous cholecyst drainage (PTGBD) before alcohol
? A person who is required to install a drainage tube during surgery
? People who overreact to cephalosporin antibiotics.
? A person who participates in another clinical trial within 3 months prior to screening
? Other persons deemed unfit for participation in this clinical trial by the tester;

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of postoperative infection-related complications

Secondary Outcome Measures

Name	Time	Method
pain after surgery;length of hospitalization;Re-admission;complications other than infection